Maryland Sleep Society
Home
Membership
Events
  • 2026 Annual Conference
  • 2026 Spring Meeting
  • 2025 Annual Meeting
Exhibitors
About Us
  • Mission Statement
  • Board of Directors
  • Award Winners
  • Bylaws
Contact Us
Employment Opportunities
  • Post a Job
  • Current Openings
Newsletters
Resources
Maryland Sleep Society
Home
Membership
Events
  • 2026 Annual Conference
  • 2026 Spring Meeting
  • 2025 Annual Meeting
Exhibitors
About Us
  • Mission Statement
  • Board of Directors
  • Award Winners
  • Bylaws
Contact Us
Employment Opportunities
  • Post a Job
  • Current Openings
Newsletters
Resources
More
  • Home
  • Membership
  • Events
    • 2026 Annual Conference
    • 2026 Spring Meeting
    • 2025 Annual Meeting
  • Exhibitors
  • About Us
    • Mission Statement
    • Board of Directors
    • Award Winners
    • Bylaws
  • Contact Us
  • Employment Opportunities
    • Post a Job
    • Current Openings
  • Newsletters
  • Resources
  • Home
  • Membership
  • Events
    • 2026 Annual Conference
    • 2026 Spring Meeting
    • 2025 Annual Meeting
  • Exhibitors
  • About Us
    • Mission Statement
    • Board of Directors
    • Award Winners
    • Bylaws
  • Contact Us
  • Employment Opportunities
    • Post a Job
    • Current Openings
  • Newsletters
  • Resources

Spring Business Meeting

 Join us for the Maryland Sleep Society 2026 Spring Business Meeting on April 29, 2026, an exclusive gathering for members committed to advancing sleep health, education, and clinical excellence across the region. This members-only event offers a valuable opportunity to stay current on emerging therapies, strengthen professional connections, and engage with colleagues throughout Maryland’s sleep-medicine community.


We are pleased to welcome Ashtaad Dalal, MD as our featured speaker. In addition to his clinical leadership, Dr. Dalal currently serves as President of the DC Sleep Society, bringing a unique regional perspective to our program. He will present an in-depth discussion on Zepbound, the first FDA-approved medication for the treatment of moderate-to-severe OSA in adults with obesity—an important therapeutic development shaping the future of patient care.


This session is designed for clinicians, technologists, and allied health professionals seeking to expand their understanding of new treatment pathways and their real-world clinical applications.

Please note: This event is open exclusively to Maryland Sleep Society members. Spots are limited, and registration will close on April 22.


We encourage you to reserve your spot and join us for an informative and engaging evening.

Register Here

Maryland Sleep Society

2821 Emerywood Parkway, Richmond, VA, USA

804-643-6631

Copyright © 2026 Maryland Sleep Society - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept